Does the media favor GEN or DLB?

In the previous week, Gen Digital had 25 more articles in the media than Dolby Laboratories. MarketBeat recorded 33 mentions for Gen Digital and 8 mentions for Dolby Laboratories. Dolby Laboratories' average media sentiment score of 0.94 beat Gen Digital's score of 0.79 indicating that Dolby Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gen Digital 11 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Dolby Laboratories 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DLB or NTNX?

In the previous week, Nutanix had 2 more articles in the media than Dolby Laboratories. MarketBeat recorded 10 mentions for Nutanix and 8 mentions for Dolby Laboratories. Dolby Laboratories' average media sentiment score of 0.94 beat Nutanix's score of 0.63 indicating that Dolby Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nutanix 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NLOK or DLB?

Dolby Laboratories has a consensus price target of $90.75, suggesting a potential upside of 47.98%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dolby Laboratories is more favorable than NortonLifeLock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NortonLifeLock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Dolby Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media refer more to DLB or RBRK?

In the previous week, Rubrik had 9 more articles in the media than Dolby Laboratories. MarketBeat recorded 17 mentions for Rubrik and 8 mentions for Dolby Laboratories. Dolby Laboratories' average media sentiment score of 0.94 beat Rubrik's score of 0.74 indicating that Dolby Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rubrik 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Dolby Laboratories (DLB) Competitors

$61.33 -0.77 (-1.24%)

Closing price 08/11/2026 03:59 PM Eastern

Extended Trading

$61.90 +0.57 (+0.93%)

As of 04:01 AM Eastern

Compare

DLB vs. GEN, NTNX, NLOK, RBRK, and CHKP

Should you buy Dolby Laboratories stock or one of its competitors? Dolby Laboratories's main competitors and comparable companies include Gen Digital (GEN), Nutanix (NTNX), NortonLifeLock (NLOK), Rubrik (RBRK), and Check Point Software Technologies (CHKP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does Dolby Laboratories compare to Gen Digital?

Gen Digital (NASDAQ:GEN) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Gen Digital pays an annual dividend of $0.50 per share and has a dividend yield of 1.7%. Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.3%. Gen Digital pays out 29.1% of its earnings in the form of a dividend. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

81.4% of Gen Digital shares are owned by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are owned by institutional investors. 9.7% of Gen Digital shares are owned by insiders. Comparatively, 37.9% of Dolby Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Gen Digital has higher revenue and earnings than Dolby Laboratories. Gen Digital is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gen Digital	$5B	3.47	$973M	$1.72	16.87
Dolby Laboratories	$1.35B	4.26	$255.02M	$2.35	26.10

In the previous week, Gen Digital had 25 more articles in the media than Dolby Laboratories. MarketBeat recorded 33 mentions for Gen Digital and 8 mentions for Dolby Laboratories. Dolby Laboratories' average media sentiment score of 0.94 beat Gen Digital's score of 0.79 indicating that Dolby Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gen Digital	11 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Dolby Laboratories	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Gen Digital has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Gen Digital has a net margin of 20.73% compared to Dolby Laboratories' net margin of 16.70%. Gen Digital's return on equity of 55.93% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Gen Digital	20.73%	55.93%	8.91%
Dolby Laboratories	16.70%	11.08%	9.04%

Gen Digital presently has a consensus target price of $31.67, indicating a potential upside of 9.16%. Dolby Laboratories has a consensus target price of $90.75, indicating a potential upside of 47.98%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Dolby Laboratories is more favorable than Gen Digital.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gen Digital	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.33
Dolby Laboratories	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Dolby Laboratories beats Gen Digital on 11 of the 20 factors compared between the two stocks.

How does Dolby Laboratories compare to Nutanix?

Dolby Laboratories (NYSE:DLB) and Nutanix (NASDAQ:NTNX) are both technology companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Dolby Laboratories has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Nutanix has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Dolby Laboratories currently has a consensus target price of $90.75, indicating a potential upside of 47.98%. Nutanix has a consensus target price of $60.00, indicating a potential downside of 6.72%. Given Dolby Laboratories' higher possible upside, analysts clearly believe Dolby Laboratories is more favorable than Nutanix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Nutanix	0 Sell rating(s)	7 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.65

Dolby Laboratories has a net margin of 16.70% compared to Nutanix's net margin of 10.03%. Dolby Laboratories' return on equity of 11.08% beat Nutanix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Nutanix	10.03%	-38.96%	8.55%

Dolby Laboratories has higher earnings, but lower revenue than Nutanix. Dolby Laboratories is trading at a lower price-to-earnings ratio than Nutanix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.26	$255.02M	$2.35	26.10
Nutanix	$2.54B	6.85	$188.37M	$0.95	67.71

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 85.3% of Nutanix shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by insiders. Comparatively, 2.4% of Nutanix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Nutanix had 2 more articles in the media than Dolby Laboratories. MarketBeat recorded 10 mentions for Nutanix and 8 mentions for Dolby Laboratories. Dolby Laboratories' average media sentiment score of 0.94 beat Nutanix's score of 0.63 indicating that Dolby Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nutanix	4 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Dolby Laboratories beats Nutanix on 9 of the 17 factors compared between the two stocks.

How does Dolby Laboratories compare to NortonLifeLock?

NortonLifeLock (NASDAQ:NLOK) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, media sentiment and valuation.

94.9% of NortonLifeLock shares are held by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are held by institutional investors. 3.3% of NortonLifeLock shares are held by company insiders. Comparatively, 37.9% of Dolby Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NortonLifeLock has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

In the previous week, Dolby Laboratories had 8 more articles in the media than NortonLifeLock. MarketBeat recorded 8 mentions for Dolby Laboratories and 0 mentions for NortonLifeLock. Dolby Laboratories' average media sentiment score of 0.94 beat NortonLifeLock's score of 0.00 indicating that Dolby Laboratories is being referred to more favorably in the news media.

Company	Overall Sentiment
NortonLifeLock	Neutral
Dolby Laboratories	Positive

NortonLifeLock pays an annual dividend of $0.50 per share and has a dividend yield of 1.7%. Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.3%. NortonLifeLock pays out 35.0% of its earnings in the form of a dividend. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

NortonLifeLock has higher revenue and earnings than Dolby Laboratories. NortonLifeLock is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NortonLifeLock	$2.82B	5.94	$817.05M	$1.43	20.48
Dolby Laboratories	$1.35B	4.26	$255.02M	$2.35	26.10

Dolby Laboratories has a net margin of 16.70% compared to NortonLifeLock's net margin of 0.00%. Dolby Laboratories' return on equity of 11.08% beat NortonLifeLock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NortonLifeLock	N/A	N/A	N/A
Dolby Laboratories	16.70%	11.08%	9.04%

Dolby Laboratories has a consensus price target of $90.75, suggesting a potential upside of 47.98%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dolby Laboratories is more favorable than NortonLifeLock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NortonLifeLock	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Dolby Laboratories	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Dolby Laboratories beats NortonLifeLock on 14 of the 19 factors compared between the two stocks.

How does Dolby Laboratories compare to Rubrik?

Dolby Laboratories (NYSE:DLB) and Rubrik (NYSE:RBRK) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Dolby Laboratories has a net margin of 16.70% compared to Rubrik's net margin of -20.25%. Dolby Laboratories' return on equity of 11.08% beat Rubrik's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Rubrik	-20.25%	N/A	-10.27%

Dolby Laboratories presently has a consensus price target of $90.75, indicating a potential upside of 47.98%. Rubrik has a consensus price target of $94.20, indicating a potential downside of 2.97%. Given Dolby Laboratories' higher possible upside, equities analysts plainly believe Dolby Laboratories is more favorable than Rubrik.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Rubrik	1 Sell rating(s)	0 Hold rating(s)	29 Buy rating(s)	0 Strong Buy rating(s)	2.93

Dolby Laboratories has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Rubrik has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

In the previous week, Rubrik had 9 more articles in the media than Dolby Laboratories. MarketBeat recorded 17 mentions for Rubrik and 8 mentions for Dolby Laboratories. Dolby Laboratories' average media sentiment score of 0.94 beat Rubrik's score of 0.74 indicating that Dolby Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rubrik	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 49.5% of Rubrik shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by company insiders. Comparatively, 13.7% of Rubrik shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Dolby Laboratories has higher revenue and earnings than Rubrik. Rubrik is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.26	$255.02M	$2.35	26.10
Rubrik	$1.32B	15.18	-$348.83M	-$1.45	N/A

Summary

Dolby Laboratories beats Rubrik on 11 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to Check Point Software Technologies?

Check Point Software Technologies (NASDAQ:CHKP) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Check Point Software Technologies has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

98.5% of Check Point Software Technologies shares are held by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are held by institutional investors. 29.0% of Check Point Software Technologies shares are held by insiders. Comparatively, 37.9% of Dolby Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Check Point Software Technologies has a net margin of 37.93% compared to Dolby Laboratories' net margin of 16.70%. Check Point Software Technologies' return on equity of 38.80% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check Point Software Technologies	37.93%	38.80%	15.60%
Dolby Laboratories	16.70%	11.08%	9.04%

Check Point Software Technologies has higher revenue and earnings than Dolby Laboratories. Check Point Software Technologies is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check Point Software Technologies	$2.73B	4.84	$1.06B	$9.77	13.22
Dolby Laboratories	$1.35B	4.26	$255.02M	$2.35	26.10

Check Point Software Technologies currently has a consensus target price of $149.67, indicating a potential upside of 15.91%. Dolby Laboratories has a consensus target price of $90.75, indicating a potential upside of 47.98%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dolby Laboratories is more favorable than Check Point Software Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check Point Software Technologies	0 Sell rating(s)	19 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.32
Dolby Laboratories	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Check Point Software Technologies had 3 more articles in the media than Dolby Laboratories. MarketBeat recorded 11 mentions for Check Point Software Technologies and 8 mentions for Dolby Laboratories. Check Point Software Technologies' average media sentiment score of 1.04 beat Dolby Laboratories' score of 0.94 indicating that Check Point Software Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Check Point Software Technologies	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Dolby Laboratories	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Check Point Software Technologies beats Dolby Laboratories on 11 of the 16 factors compared between the two stocks.

Get Dolby Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DLB vs. The Competition

Export

Metric	Dolby Laboratories	Software Industry	Technology Sector	NYSE Exchange
Market Cap	$5.82B	$16.01B	$29.77B	$24.25B
Dividend Yield	2.32%	3.42%	2.73%	3.70%
P/E Ratio	26.10	127.02	74.95	30.36
Price / Sales	4.26	1,304.48	600.07	20.43
Price / Cash	14.54	46.92	51.24	33.15
Price / Book	2.22	6.98	9.25	6.54
Net Income	$255.02M	$437.03M	$678.40M	$1.06B
7 Day Performance	0.03%	1.03%	1.44%	0.35%
1 Month Performance	23.35%	1.95%	0.43%	2.41%
1 Year Performance	-15.24%	8.54%	196.14%	18.19%

Dolby Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DLB Dolby Laboratories	4.8328 of 5 stars	$61.33 -1.2%	$90.75 +48.0%	-14.5%	$5.82B	$1.35B	26.10	2,051
GEN Gen Digital	4.4348 of 5 stars	$28.17 +2.6%	$29.33 +4.1%	-5.7%	$16.43B	$5B	17.83	3,900	Earnings Report Dividend Announcement Options Volume
NTNX Nutanix	3.0568 of 5 stars	$61.06 +3.5%	$60.00 -1.7%	-6.5%	$15.95B	$2.54B	64.27	7,800	Short Interest Decrease
NLOK NortonLifeLock	N/A	$27.45 +0.6%	N/A	-3.8%	$15.68B	$2.82B	19.20	N/A
RBRK Rubrik	2.5378 of 5 stars	$74.71 +3.3%	$94.20 +26.1%	+13.3%	$14.89B	$1.32B	N/A	3,797

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DLB) was last updated on 8/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dolby Laboratories (DLB) Competitors

DLB vs. GEN, NTNX, NLOK, RBRK, and CHKP

How does Dolby Laboratories compare to Gen Digital?

Summary

How does Dolby Laboratories compare to Nutanix?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Summary

How does Dolby Laboratories compare to Rubrik?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dolby Laboratories (DLB) Competitors

DLB vs. GEN, NTNX, NLOK, RBRK, and CHKP

How does Dolby Laboratories compare to Gen Digital?

Is GEN or DLB a better dividend stock?

Do institutionals and insiders hold more shares of GEN or DLB?

Which has preferable valuation and earnings, GEN or DLB?

Does the media favor GEN or DLB?

Which has more volatility & risk, GEN or DLB?

Is GEN or DLB more profitable?

Do analysts prefer GEN or DLB?

Summary

How does Dolby Laboratories compare to Nutanix?

Which has more risk and volatility, DLB or NTNX?

Do analysts prefer DLB or NTNX?

Is DLB or NTNX more profitable?

Which has better valuation & earnings, DLB or NTNX?

Do insiders and institutionals have more ownership in DLB or NTNX?

Does the media prefer DLB or NTNX?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Do institutionals and insiders hold more shares of NLOK or DLB?

Which has more volatility and risk, NLOK or DLB?

Does the media prefer NLOK or DLB?

Is NLOK or DLB a better dividend stock?

Which has better valuation & earnings, NLOK or DLB?

Is NLOK or DLB more profitable?

Do analysts prefer NLOK or DLB?

Summary

How does Dolby Laboratories compare to Rubrik?

Is DLB or RBRK more profitable?

Do analysts recommend DLB or RBRK?

Which has more risk & volatility, DLB or RBRK?

Does the media refer more to DLB or RBRK?

Do institutionals & insiders have more ownership in DLB or RBRK?

Which has stronger earnings and valuation, DLB or RBRK?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Which has more risk and volatility, CHKP or DLB?

Do insiders & institutionals have more ownership in CHKP or DLB?

Is CHKP or DLB more profitable?

Which has preferable valuation & earnings, CHKP or DLB?

Do analysts recommend CHKP or DLB?

Does the media favor CHKP or DLB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools